William Arsani
SEC insider (Form 3/4/5 filer). CIK 0001848372. Director at Design Therapeutics, Inc. (DSGN). 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 13, 2025. Located in CARLSBAD, CA.
Companies William Arsani has filed insider reports for
- Design Therapeutics, Inc. (DSGN): Director
William Arsani
CIK: 0001848372
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DSGN
Design Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Aug 13, 2025DSGN
Design Therapeutics, Inc.
SaleIndirect345K shares at avg. $5.25$1.8M - Aug 13, 2025DSGN
Design Therapeutics, Inc.
SaleIndirect217.6K shares at avg. $5.25$1.1M - Jun 10, 2025DSGN
Design Therapeutics, Inc.
AwardDirectStock Option (right to buy)
19K shares-
1-3 of 3 transactions